Psychological predictors for attendance of post-HIV test counselling and linkage to care: the Umeed cohort study in Goa, India. by Mayston, Rosie et al.
Mayston, Rosie; Patel, Vikram; Abas, Melanie; Korgaonkar, Priya;
Paranjape, Ramesh; Rodrigues, Savio; Prince, Martin (2014) Psy-
chological predictors for attendance of post-HIV test counselling and
linkage to care: the Umeed cohort study in Goa, India. BMC PSY-
CHIATRY, 14 (1). ISSN 1471-244X DOI: https://doi.org/10.1186/1471-
244X-14-188
Downloaded from: http://researchonline.lshtm.ac.uk/4651371/
DOI: 10.1186/1471-244X-14-188
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
RESEARCH ARTICLE Open Access
Psychological predictors for attendance of
post-HIV test counselling and linkage to care: the
Umeed cohort study in Goa, India
Rosie Mayston1*, Vikram Patel2,3, Melanie Abas1, Priya Korgaonkar3, Ramesh Paranjape4, Savio Rodrigues5
and Martin Prince1
Abstract
Background: Successful linkage to care is increasingly recognised as a potentially important factor in determining
the success of Antiretroviral Therapy treatment programmes. However, the role of psychological factors during the
early part of the continuum of care has so far been under-investigated. The objective of the Umeed study was to
evaluate the impact of Common Mental Disorder (CMD), hazardous alcohol use and low cognitive functioning upon
attendance for post-test counselling and linkage to care among people attending for HIV-testing in Goa, India.
Methods: The study was a prospective cohort design. Participants were recruited at the time of attending for
testing and were asked to complete a baseline interview covering sociodemographic characteristics and mental
health exposures. HIV status, post-test counselling (PTC) and Antiretroviral Treatment (ART) Centre data were
extracted from clinical records.
Results: Among 1934 participants, CMD predicted non-attendance for PTC (adjusted OR = 0.51, 0.21-0.82). There
was tentative evidence of an association between hazardous alcohol use and non-attendance for PTC (adjusted
OR = 0.69, 0.45-1.02). There was no evidence of an association between CMD caseness and attendance for ART.
However, post-hoc analyses showed an association between increasing symptoms of CMD and non-attendance.
Conclusions: Although participation rates were high (86%), non-participation was a possible source of bias.
Cognitive tests had not been previously validated in a young population in Goa. The context in which cognitive
testing took place may have contributed to the high prevalence of low scores. Findings suggest the need to move
towards a broader conceptualisation of the interrelationship between mental health and HIV. It may be important
to consider the impact of symptoms of depression and anxiety at every stage of the continuum of care, including
immediately after diagnosis and when initiating contact with treatment services.
Keywords: Linkage to care, Depression, Anxiety, HIV testing, Cognitive impairment, India
Background
Timely presentation at services and minimisation of
delays in initiation of treatment have been identified as
potentially important contributory factors to reducing
the high levels of early mortality observed in treatment
programmes for HIV/AIDS [1,2]. Recent research car-
ried out among people living with HIV/AIDS has led to
wider recognition of the important contribution of
mental disorder, in particular, depression, to HIV clin-
ical outcomes. People living with HIV have a high
prevalence of depression and other common mental
disorders (CMD), alcohol use disorders, and neurocog-
nitive impairment [3,4]. These conditions are associated
with poor adherence to antiretroviral therapy [5-7] dis-
ease progression and mortality [8]. However, we know
very little about the impact of adverse mental health on
engagement with services early in the continuum of
care for HIV/AIDS.
The mental health of people coming for HIV testing
has been assessed in just three low or middle income
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country (LMIC) studies [9-11]. Only one, from South
Africa, examined the association of mental health with
an aspect of linkage to care [11]. Authors found that de-
pression was independently associated with failing to
obtain a CD4 count (after being referred for testing by a
healthcare provider) (RR = 0 · 82, 0 · 72-0 · 94). No other
studies were identified that specifically examined the
impact of either CMD or neurocognitive impairment
upon attendance for post-test counselling, or linkage to
care after diagnosis.
The aim of the “Umeed” study, carried out in Goa, India
was to investigate the independent impact of symptoms of
CMD, hazardous and dependent alcohol use and cognitive
impairment on two early outcomes in the pathway to
treatment: attendance both for post-test counselling and
initial presentation at treatment services after diagnosis
and referral (linkage to care). (“Umeed” means “hope” in
Hindi and was chosen as an appropriate study name by
team members).
Methods
Study design
The “Umeed” project was a prospective cohort study.
Participants were recruited at the time of attending for
pre-test counselling and testing at Goa Medical College.
Structured baseline interviews were carried out by re-
search assistants on-site, at the time of this first visit.
Follow-up data on HIV status, attendance for post-test
counselling, and (for those found to be HIV positive)
attendance at an ART treatment centre for initial as-
sessment was obtained through data linkage to routine
clinical records.
Setting and participants
Goa is an Indian state with a population of 1 · 34 million
(Government of Goa, 2010). For the purposes of HIV/
AIDS surveillance, Goa is divided into two districts: the
north is one of India’s high prevalence districts, with
more than one percent of women testing positive at
antenatal care while the south is medium prevalence,
with a high level of HIV/AIDS among high-risk groups
(more than five percent prevalence among those attending
STI clinics) (UNGASS, 2008). The cohort was recruited
from attendees of the Integrated Counselling and Testing
Centre (ICTC) at Goa Medical College (GMC), which
serves both the north and south districts and is the largest
public testing centre in the state, conducting seventy
percent of tests in 2006 (n = 7664). Participants were
recruited between January 2008 and January 2010 and
followed-up until March 2010.
Participant recruitment
Participants were recruited at the time of attending the
ICTC for pre-test counselling and testing, as “walk-in”
clients (self-referrals, or primary care physician referrals)
or those formally referred for testing by doctors from
other GMC departments. Individuals whose purpose for
attending the ICTC was to undertake pre-test counselling
and a HIV blood test were eligible to take part. Other in-
clusion criteria were fluency in Konkani, Hindi, or English
and a lower age limit of 18 years. Written informed con-
sent for participation and data linkage with test results
was sought from all potential participants. (A thumb print
to indicate consent and the signature of an independent
witness was sought from those unable to sign their names
due to low literacy). Questionnaires were extensively
piloted among people coming for testing for HIV in Goa
to ensure that questions included in the final version of
the questionnaire were well understood among this popu-
lation. The study was approved by local and international
research ethics committees (Sangath, Indian Council for
Medical Research and King’s College London).
Measures
Questions relating to sociodemographic characteristics,
HIV-related behaviours, beliefs and knowledge (transmis-
sion and prevention knowledge, disclosure plans, sexual
behaviour, knowledge and symptoms of sexually transmit-
ted infections) and a screening assessment for mental,
substance and alcohol use disorders and cognitive testing
were included in the baseline interviews. Basic sociodemo-
graphic data were collected from those who declined to
participate.
Common Mental Disorder (CMD): To identify clinically
relevant symptoms of depression, anxiety and panic, com-
ponents of the Patient Health Questionnaire, comprising
the brief PHQ-9, the seven item Generalised Anxiety
Disorder scale (GAD-7), and the panic disorder module
[12] were included in the baseline questionnaire. The
PHQ-9 has been previously validated in Goa for the de-
tection of CMD in primary care and was one of five in-
struments to achieve an area under the curve (AUC)
from receiver operating characteristic analysis of at least
0 · 80 (0 · 84 for the PHQ-9) [13]. In the Umeed study, as
recommended by Spitzer et al. [12], a cut-off of ten was
used as an indicator of clinically relevant major depres-
sion. A cut-off of ten for the GAD 7 was used to define
clinically relevant generalised anxiety [14]. Participants
reporting “yes” to each of the first four questions relating
to panic attacks were considered probable panic disorder
cases. At the time of conducting the study, there were
no measures of anxiety symptoms that had been vali-
dated in a local HIV-affected population. Therefore, we
decided to use brief measures and recommended cut-offs
that showed good validity in primary care and outpatient
populations elsewhere [15]. Participants thus identified
as having symptoms, to a clinically significant degree, of
either major depression or generalised anxiety disorder
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or panic disorder were categorised as screening positive
for a common mental disorder. The rationale for this
approach is the high level of comorbidity between these
disorders, their close underlying nosological relationship
[16] and the likely common mechanisms (psychological
distress, disability and negative cognitions) affecting HIV
service engagement. It is important to note that the
cut-points applied establish a high probability of having
the relevant disorders, but do not constitute a clinical
diagnosis.
Alcohol Use Disorder (AUD): The AUDIT is a ten
item questionnaire designed to screen for hazardous and
harmful drinking (WHO, 2001), assessing consumption,
dependence and alcohol related problems (WHO, 2001).
The instrument has been widely used in India [17] includ-
ing Goa [18]. A recent validity study in Goa demonstrated
good sensitivity and specificity, with an area under the
curve of 0 · 87 when compared to alcohol abuse and
dependency criteria. We used the lower cut-point of
eight or above, validated in most primary care studies
as the optimal threshold for identifying hazardous or
harmful drinking and used in US national alcohol sur-
veys [19,20]. These individuals (including hazardous
and dependent drinkers) are subsequently referred to
as screening positive for an alcohol use disorder.
Cognitive impairment: The two measures of cognitive
functioning included were word list learning (assessing
memory) and animal naming (measuring verbal fluency,
an aspect of executive functioning, known to be a com-
mon deficit in people living with HIV/AIDS [21]. Inter-
viewers read out a ten word list (adapted for use in
India [22]) three times. Participants were asked to recall
the list of words immediately after each reading and fi-
nally requested to recall words after a delay of several
minutes in which another section of the questionnaire
was completed. This final delayed recall total out of ten
was recorded. For the animal naming test, participants
were asked to tell the interviewer as many different
types of animals as they could recall during one minute.
These tests originate from the Consortium to Establish
a Registry of Alzheimer’s Disease (CERAD) test battery
and have been validated among older people in Goa as
part of the development of a cross-cultural diagnostic
instrument for dementia [23]. Education-specific norms
(1 · 5 standard deviations below the mean) for the youn-
gest age-group studied (60–64 years) were used to indicate
likely cognitive impairment.
Outcome measures
At pre-test counselling, service-users were requested to
return for test results after one week. At post-test counsel-
ling, those who received a positive test result were advised
to attend the ART Centre (at the same hospital) as soon
as possible in order to undergo further assessment of
disease status and treatment eligibility.
Outcome data were collected from routine clinical re-
cords maintained by ICTC and ART Centre staff by an
Umeed team member not involved in baseline data collec-
tion. HIV status and date of attendance for post-test coun-
selling (if attended) were extracted from ICTC records
and date of first attendance of the ART Treatment Centre,
date of attendance for CD4 count and CD4 count (for
those who attended) were extracted from ART Centre re-
cords. Study participants records were identified using the
unique identifier assigned to participants by counsellors at
pre-test counselling. Record-keeping is closely monitored
by the Head of Microbiology. The high quality is demon-
strated by the low proportion of study participants for
whom no data on attendance for post-test counselling was
available (0 · 48%, see Figure 1).
A minimum of one month follow-up after attendance
for post-test counselling was carried out for all HIV-
positive participants who had attended for post-test
counselling. Follow-up for three months was obtained
for 152 (83%); follow-up for six months was obtained for
137 (75%). Whether participants had attended within
30 days of post-test counselling was used as the cut-off
point for determining attendance/non-attendance at the
ART Centre.
Data analysis
Chi-squared tests were used to compare the sociodemo-
graphic characteristics of participants with the character-
istics of those who refused to take part in Umeed.
Our hypotheses were: a) that CMD, AUD and cognitive
impairment, assessed at attendance for HIV-testing, would
be independently associated with non-attendance for
post-test counselling; b) that the same exposures would
be independently associated with non-attendance at the
antiretroviral (ART) treatment centre (among those re-
ceiving a HIV diagnosis). In the testing of both hypotheses,
we moved from bivariate (chi-squared tests for homogen-
eity and crude odds ratios) to multivariate analyses (logistic
regression), adjusting for potential confounders. Criteria for
inclusion in final models were: a) variables considered a
priori confounders (for example, association of impaired
cognitive functioning with AUD and CMD); or b) variables
selected using a “change in estimate” method ie. those that
resulted in a significant change in the effect of exposure of
interest upon outcome (more than 10 percent change in
odds ratio). We were interested to see whether HIV status
had a modifying effect upon any observed associations
between psychological variables and attendance out-
comes as differential impact by HIV status has poten-
tially important implications for service providers and
policymakers. In the test of the first hypothesis we in-
troduced an interaction term (psychological exposure
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by HIV status) as a sensitivity analysis in the final stage
of modelling. Due to the negligible prevalence of AUD
among women (0 · 9 percent), all analyses of alcohol use
were carried out using a men-only sample (n = 915). To
explore the independent effects of depression and anx-
iety symptoms upon attendance of the ART Centre and
attendance for post-test counselling, post-hoc analyses
were carried out. PHQ-9 and GAD-7 scores were divided
into four categories (0, 1–4, 5–9, >10 points). In order to
test the associations between depression and anxiety
symptom categories and each of the attendance outcomes,
we used the same approach as that used in the testing of
the a priori hypotheses.
Results
Sample characteristics
2783 participants attended the ICTC for pre-test counsel-
ling during the study period. Of the 2613 attendees
screened for Umeed, 2279 were deemed eligible to take
part in the study. Of these, 315 (13 · 8%) declined to par-
ticipate, hence 1934 were enrolled in Umeed (see Figure 1).
Those who refused were more likely to originate from
Goa, to be Christian as opposed to Hindu or Muslim, and
to have lower levels of education (Additional file 1:
Table S1).
See Table 1 for sociodemographic characteristics of the
sample. The prevalence of any CMD was 5 · 4 percent.
Depression was the most common CMD disorder- of
those with any CMD, 80 percent scored 10 or more on
the PHQ-9. 13 · 3 percent of participants screened posi-
tive for AUD (27 percent among men). Around a quarter
of the sample scored below the educational norm on
two cognitive tests of delayed recall (23 · 1 percent) and
verbal fluency (25 · 9 percent). Prevalence of non-prescribed
drug use was very low (1 · 3 percent) (not presented in
table). Eleven percent of the sample tested seropositive
for HIV.
Pathway through services
Of those tested, 1,684 (87 · 1%) attended post-test coun-
selling, of whom 183 (10 · 9%) were seropositive. 250 did
not attend post-test counselling, of whom 38 (15 · 2%)
were seropositive. Of the 183 individuals who received
their positive test results, and were referred to the ART
Screened
2613
Missed 170 (6.1%)
Eligible
2279
Available for analysis
1934
Refused 315 (15.4%)
Interviews lost due to palmtop 
malfunction 19 (0.8%)
No post-test counselling follow-up 
data available 11 (0.5%)
Attended PTC
1684 (87.1%)
Seropositive attended PTC
183 (10.9%)
Attended ART Centre within 
1m of results
122 (66.7%)
Seronegative attended PTC
1501 (89.1%)
Did not attend ART Centre 
within 1m of results
61 (33%)
CD4 count
104 (85.2%)
No CD4 count
20 (16.4%)
CD4 <200
41 (39.4%)
CD4>200
63 (60.6%)
Attended
2783
Ineligible 334 (12.8%)
Did not attend PTC
250 (12.9%)
Figure 1 Pathways through HIV services.
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Table 1 Bivariate analysis of association of mental health and demographic variables with attendance of post-test
counselling
Variable Prevalence among
total sample N (%)
Attendance of PTC
among exposure
category N (%)
Unadjusted OR with 95%
confidence interval
P-value
Total 1934 (100.00) 1684 (87.07)
Symptoms of common mental disorder 104 (5.38) 80 (76.92) 0.47 (0.29-0.76) <0.01
Hazardous alcohol use (men only) 257 (13.29) 212 (82.49) 0.66 (0.46-0.93) 0.02
Cognitive functioning
Delayed recall: scored below educational norm 466 (23.06) 380 (85.20) 1.31 (0.99-1.75) 0.06
Verbal fluency: scored below educational norm 500 (25.85) 429 (85.80) 0.81 (0.60-1.10) 0.18
Male 915 (47.31) 784 (81.75) 1.00
Female 1019 (52.69) 900 (85.87) 1.36 (1.06-1.73) 0.01
Age Overall test for trend 0.04
18-25 444 (22.96) 371 (83.56) 1.00
26-30 368 (19.03) 325 (88.32) 1.49 (0.99-2.23) 0.06
31-34 307 (15.87) 266 (86.64) 1.28 (0.84-1.93) 0.25
35-40 299 (15.46) 266 (88.96) 1.59 (1.02-2.46) 0.04
41-45 168 (8.69) 145 (86.31) 1.24 (0.75-2.06) 0.40
46-50 155 (8.01) 141 (90.97) 1.98 (1.08-3.62) 0.03
50+ 193 (9.98) 170 (88.08) 1.45 (0.88-2.40) 0.14
Religion Overall test for heterogeneity 0.60
Hindu 1406 72.70 1223 (86.98) 1.00
Christian 316 16.34 275 (87.03) 1.00 (0.70-1.44) 0.98
Muslim 209 10.83 184 (88.04) 1.10 (0.71-1.72) 0.67
Other 3 0.15 2 (66.67) 0.30 (0.03-3.32) 0.33
Marital status Overall test for heterogeneity 0.01
Married/co-habiting 1351 (69.86) 1195 (88.45) 1.00
Widowed 16 (0.83) 16 (100.00) ——— ———— 0.15
Separated/divorced 138 (7.14) 117 (84.78) 0.73 (0.44-1.19) 0.21
Never married 429 (22.18) 356 (82.98) 0.64 (0.47-0.86) <0.01
Education Overall test for trend 0.50
None 350 (18.10) 303 (86.57) 1.00
Primary school 485 (25.08) 429 (88.45) 1.19 (0.78-1.80) 0.42
Secondary school 941 (48.66) 820 (87.14) 1.05 (0.73-1.51) 0.79
Further education 158 (8.17) 132 (83.54) 0.79 (0.47-1.33) 0.37
Employment
Paid employee 998 (51.60) 858 (85.97) 1.00 Overall test for heterogeneity 0.09
Student 50 (2.59) 38 (76.00) 0.52 (0.26-1.01) 0.06
Seasonal work 44 (2.28) 38 (86.36) 1.03 (0.43-2.49) 0.94
Self-employed: small-scale business 58 (3.00) 53 (91.38) 1.73 (0.68-4.40) 0.25
Owns business 107 (5.53) 92 (85.98) 1.00 (0.56-1.78) 1.00
Unemployed 243 (12.56) 218 (89.71) 1.42 (0.91-2.23) 0.13
No work outside home 434 (22.44) 387 (89.17) 1.34 (0.95-1.91) 0.10
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Centre for initial assessment, 122 (66 · 7%) attended
within one month of receiving test results. Only two par-
ticipants attended the ART Centre after 30 days.
Mental health and attendance for post-test counselling
Attendance for post-test counselling was lower among
those screening positive for CMD (Table 1) (crude odds
ratio [OR] 0 · 47, 95% CI 0 · 29-0 · 76, and for those
screening positive for AUD (OR 0 · 67, 95% CI 0 · 45-0 · 99).
Low cognitive function (as measured by either test) was
not found to be associated with attendance for post-test
counselling. Those testing positive for HIV (OR 0 · 68,
95% CI 0 · 47-0 · 99), younger clients, men, and those
not currently married were also less likely to attend.
After controlling for sex, HIV status, cognitive impair-
ment and AUD, the association between screening positive
for CMD and non-attendance for post-test counselling
was little changed (Adjusted OR 0 · 51, 95% CI 0 · 30-0 ·
82). After adjusting for the effects of sex, employment
status, HIV status, CMD and cognitive functioning; the
association between screening positive for AUD (AOR
0 · 69, 95% CI 0 · 45-1 · 03), was little changed, but no
longer statistically significant. Although the association
of CMD and AUD upon attendance for post-test counsel-
ling was larger among seropositive than seronegative par-
ticipants, there was no evidence for effect modification of
the association with CMD (Model 4, Table 2) or AUD
(Model 8, Table 2).
Associations with linkage to care
Among those people who tested positive for HIV and were
therefore eligible for ART, bivariate analyses showed no
relationships between CMD or cognitive impairment and
attendance for such treatment (Table 3).
Post-hoc analyses
We carried out exploratory analyses to examine associa-
tions between PHQ-9 and GAD-7 score categories and
ART Centre attendance, obtaining a CD4 count, having
a low CD4 count (<200/ml3), attendance of post-test
counselling. Exploratory analyses suggested an associ-
ation between depressive symptoms (PHQ-9 score) and
attendance at the ART Centrethat was robust to con-
trolling for the effects of sex, age, marital status and em-
ployment, but with reduced odds of attendance among
all groups scoring any depression symptoms (Additional
file 1: Table S2). The odds of attendance declined mono-
tonically with increasing numbers of depression and
anxiety symptoms regardless of adjustment for potential
confounders (Additional file 1: Table S2). Neither PHQ-
9 score category nor GAD-7 score category were found
to be associated with obtaining a CD4 count (p = 0 · 21;
Table 1 Bivariate analysis of association of mental health and demographic variables with attendance of post-test
counselling (Continued)
Perceived likelihood of testing positive for HIV
Likely/very likely 85 (4.40) 70 (82.35) 0.68 (0.38-1.21) 0.18
HIV status
HIV-positive 221 (11.43) 183 (82.81) 0.68 (0.47-0.99) 0.05
Table 2 Multivariate analysis of association of mental health problems with attendance of post-test counselling
Model Variables OR with 95% confidence interval P-value
Analysis of association of CMD with attendance of post-test counselling
1 CMD 0.47 0.29-0.76 <0.01
2 CMD + sex 0.47 0.29-0.75 <0.01
3 Model 2 + HIV status + AUD + impaired memory + impaired animal naming 0.51 0.31-0.82 <0.01
4 Model 3 + interaction term: HIV status x CMD 0.72 0.23-2.23 0.56
Interaction term 0.40 0.15-1.07 0.07
Effect of CMD (in HIV + ve)
Analysis of association of AUD with attendance of post-test counselling (men only)
5 AUD 0.67 0.45-0.99 0.05
6 AUD + age + employment 0.63 0.42-0.95 0.03
7 Model 6 + HIV status + CMD + impaired memory + impaired animal naming. 0.69 0.45-1.03 0.07
8 Model 7 + interaction term: HIV status x AUD 0.54 0.17-1.66 0.28
Interaction term 0.40 0.14-1.15 0.09
Effect of AUD (in HIV + ve)
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p = 0 · 06, respectively) or obtaining a low count (<200/ml3)
(p = 0 · 25; p = 0 · 20, respectively).
When the same exposure definitions were tested for
the association with attendance for post-test counselling,
reduced odds of attendance seemed to be concentrated
mainly or exclusively among those scoring 10 or more
points (hence meeting the criteria to screen positive for
a CMD), before and after controlling for sex, HIV status,
hazardous alcohol use, verbal fluency and delayed recall
(Additional file 1: Table S3).
Discussion
The Umeed cohort is one of the first prospective studies
to examine the effects of psychological factors upon ac-
cess to services during the important early stages of the
continuum of care for HIV/AIDS. We hypothesised that
screening positive for CMD or AUD, and having low
scores on test of memory or verbal fluency would inde-
pendently predict non-attendance for post-test counsel-
ling, and non-contact with the ART Centre (among
those found to be seropositive for HIV). Those screening
positive for any CMD were around half as likely to at-
tend for post-test counselling. We also identified weaker
evidence for an association between screening positive
for alcohol use disorder and attendance for post-test
counselling (AOR = 0 · 69, 0 · 45-1 · 03). CMD and alcohol
use disorder had similar effects upon attendance for post-
test counselling across HIV-positive and negative groups.
Among the smaller sample of HIV-infected participants
who had attended for post-test counselling (n = 183),
planned analyses revealed no evidence of any association
between CMD and attendance at the ART Centre. How-
ever, exploratory post-hoc analyses showed that people
with symptoms of depression and anxiety were much less
Table 3 Bivariate analysis of association of mental health and demographic variables with attendance at ART Centre
within one month of testing
Variable Prevalence among those
attending post-test counselling
and receiving a positive HIV test
N (%)
Attendance at ART
Centre among exposure
categories N (%)
Unadjusted OR with
95% confidence
interval
P-value
Total 183 122 66.67
Common mental disorder 14 7.65 9 64.29 0.74 0.23-2.36 0.62
AUD (men only) 31 33.33 26 83.87 1.96 0.64-6.04 0.23
Cognitive functioning
Delayed recall. Scored below educational norm 78 42.62 54 69.23 0.82 0.44-1.53 0.53
Verbal fluency. Scored below educational norm 55 30.05 39 70.91 0.76 0.38-1.50 0.43
Male 93 50.82 71 76.34
Female 90 49.18 51 56.67 0.41 0.21-0.76 0.01
Age
Less than 35 years 88 48.09 51 57.95
More than 35 years 95 51.91 71 74.74 2.15 1.13-4.07 0.02
Religion
Hindu 123 67.96 81 65.85
Christian 43 23.26 28 65.12 2.07 0.55-7.76 0.93
Muslim 15 8.29 12 80.00 0.97 0.47-2.01 0.78
Marital status
Married/co-habiting 131 71.58 95 72.52
Not currently married 52 28.42 27 51.92 0.77 0.63-0.94 0.01
Education
Up to primary 99 54.10 65 65.66
Secondary school and above 84 45.90 57 67.86 1.10 0.59-2.05 0.75
Employment
Economically active 1120 65.57 86 71.67
Not earning money 63 34.43 36 57.14 0.53 0.28-1.01 0.05
Perceived likelihood of testing positive for HIV
Likely/very likely 53 28.96 35 66.04 1.24 0.57-2.70 0.58
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likely to attend the ART Centre compared to those with
no symptoms. Symptoms of depression and anxiety were
not associated with either obtaining a CD4 count or
having a low CD4 count (where one was obtained). We
found no evidence of any association between cognitive
impairment and engagement with HIV services.
Determinants of receipt of diagnosis among those
undergoing testing are under-researched. Studies in low
and middle income settings have tended to focus upon
demographic and HIV-related correlates of attendance
[24-27]. The only studies to examine the effects of psycho-
logical factors upon attendance for post-test counselling
were carried out in high income settings and focused
mainly on substance use [28-30]. In a sample of people
with severe mental illness no association was found be-
tween baseline psychiatric diagnostic category and attend-
ance for post-test counselling [28].
Our post-hoc analyses suggest that it is important to
consider the broader impact of symptoms of anxiety and
depression upon access to care for HIV/AIDS beyond
the clinically relevant diagnostic categories. Risk for non-
attendance for PTC was concentrated among the 5 · 4%
with clinically significant CMD, nearly a quarter of whom
did not re-attend. However, among those who received a
HIV diagnosis, attendance for assessment at the ART was
substantially reduced among all groups with any anxiety
or depression symptoms. Three-quarters of those referred
to the ART Centre had some symptoms and more than a
third of those with symptoms did not attend. The mech-
anism for these different risk thresholds could not be clari-
fied but the impact of receiving a positive test result may
be contingent upon pre-test mental state, together with
other post-diagnostic factors that might lead to an in-
crease in symptoms in this group, and/or unresolved
anger, guilt, loss and denial [31,32]. These possibilities
warrant further investigation. It will also be important
to test the effectiveness of targeted intervention during
and after post-test counselling with the aim of increasing
linkage to care.
Currently, there are few studies with which these post-
hoc findings may be compared. In a US sample of people
who had recently been diagnosed with HIV, depression
was a borderline statistically significant predictor of not
attending HIV treatment services within three months
of follow-up (AOR = 2 · 00, 95% CI = 0 · 96-4 · 14) [33]. The
small amount of research on the relationship between
mental health and linkage to care in low income settings
has tended to focus on alcohol use rather than common
mental disorder. In the STIAL study, a brief measure of
psychological distress (the MHI-5), was associated with a
small decreased risk in linkage to care (defined as obtain-
ing a CD4 count, conditional upon registering at an ART
centre). The threshold applied to the MHI-5 identified
55% of ART attendees as having psychological morbidity,
suggesting that many would have been subclinical cases.
Therefore, while caution is indicated in making inferences
from post-hoc findings, there is some independent evi-
dence that subclinical psychological morbidity may have a
negative impact on linkage to care. Also, it should be
noted that the associations in the US study and the STIAL
study were for different segments of the care pathway; in
the current study mental health was measured before
diagnosis (the US study baseline assessment was within
90 days of diagnosis). Unlike STIAL, we found no asso-
ciation between depression or anxiety symptoms and
obtaining a CD4 count, but, due to progressive attrition
these analyses were underpowered.
Limitations
Non-participation was a possible source of bias in Umeed:
although 86% of those who were screened eligible agreed
to take part, being Goan, having attained primary school
education only and being Christian were all associated
with refusal. Ethical considerations meant that it was not
possible to obtain outcome data on people who had de-
clined to participate. Although none of the demographic
factors found to be associated with participation were
associated with attendance outcomes, it cannot be
guaranteed that bias did not arise. As clinic attendees
who were “missed” for screening for eligibility -(usually
at busy times in the clinic when all researchers were
engaged with other participants) were likely to be
missed at random, we would not expect those “missed”
to bias our results.
Another potential limitation of the Umeed study is
that the cognitive tests had not previously been used or
validated in a younger adult Goan population, and edu-
cation specific norms were derived from the youngest
(60–64 year) age group from a previous study conducted
in Goa and other sites in India [23]. The high prevalence
of apparent low cognitive functioning among Umeed
participants is surprising given their broader and mainly
younger age distribution. The test context (environmental
distractions, and anxiety regarding the HIV test) may
have impaired concentration and hence performance.
The higher prevalence of impaired verbal fluency, but
not memory impairment, among those who were HIV
seropositive [34] was consistent with previous research
[35] and supports construct validity. The fact that the
high levels of cognitive impairment identified in the
Umeed sample had no effect upon attendance at post-test
counselling or linkage to care may suggest that the deficits
identified were not severe enough to impact upon partici-
pants’ ability to understand and retain information given
at time of testing, or to inhibit their ability to plan and
execute their return visit.
The quantitative study design of Umeed and the fact
that we measured mental health at a single time-point
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means that the mechanisms for the relationship between
psychological factors and service use outcomes are un-
clear. Further observational, qualitative research is neces-
sary to explore how mental health fits into the complex
networks of concerns (stigma, illness/treatment beliefs
etc.) that have been found to influence treatment-related
behaviours and outcomes [36,37].
Conclusions
As the gateway to assessment and treatment, receiving a
diagnosis at post-test counselling is an essential compo-
nent of the pathway to care. Our findings highlight the
potential importance of CMD and AUD in linkage to
care for HIV/AIDS. In particular, we found strong evi-
dence to suggest that CMD may inhibit attendance for
post-test counselling. Previous analysis of the Umeed
dataset suggested that impaired cognitive functioning
and CMD are associated with HIV seropositive status,
prior to participant’s knowledge of the test result - we
suggested that shared risk factors or underlying neuro-
logical damage due to HIV may account for this finding
[34]. Exploratory post-hoc analyses suggest that sub-
threshold symptoms of depression and anxiety at the
time of testing may decrease the probability of people
living with HIV/AIDS taking the next step in accessing
specialist care for the disease. It will be important to
carry out further prospective research to examine CMD
symptoms over time with the aim of identifying periods
of greatest risk, both in terms of severity of CMD symp-
toms and the potential adverse impact of this morbidity
upon HIV outcomes. Our findings suggest the need to
move towards a broader conceptualisation of the inter-
relationship between mental health and HIV wherein the
possible impact of symptoms of depression and anxiety
and the trajectory of mental health over time are consid-
ered at every stage of the continuum of care, from testing
to lifelong adherence. If the Umeed study findings are
replicated elsewhere, it may be important to consider
the development and evaluation of early brief psycho-
logical interventions for all those with symptoms of com-
mon mental disorders, in order to improve the mental
health and HIV outcomes (linkage with care and down-
stream clinical outcomes) of people newly diagnosed with
HIV/AIDS.
Additional file
Additional file 1: Post-hoc analyses.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MP & RM conceived of the study and planned analyses. RM carried out
analyses. VP & MA participated in the design of the study. RM & PK
co-ordinated study staff and data collection. SR provided provided on-site
supervision during data collection. RP advised on study design and ethical
considerations. All authors read and approved the final manuscript.
Acknowledgements
The Umeed study was funded by grants from Psychiatry Research Trust and
Parkes Foundation. R. Mayston was funded by a UK Medical Research
Council PhD Studentship. We are grateful to National AIDS Control
Organisation for approving the Umeed study. We are grateful to the Umeed
research team: Priti Girap, Supriya Harmalkar, Rakesh Kumar. Thanks also to
Neerja Chowdhary, Maryam Shahmanesh, Smita Naik and the staff at the
Goa Medical College Integrated Counselling and Testing Centre. And thanks
to all those who took part in the study.
Author details
1Health Service & Population Research Department, Institute of Psychiatry,
Kings College London, London SE5 8AF, UK. 2Department of Nutrition and
Public Health Intervention Research, London School of Hygiene & Tropical
Medicine, London WC1E 7HT, UK. 3Sangath, North Goa: 841/1, Near Electricity
Department, Alto Porvorim, Bardez-Goa, India. 4National AIDS Research
Institute, 73, 'G'-Block, MIDC, Bhosari Pune 411 026, India. 5Department of
Microbiology, Goa Medical College and Hospital, Bambolim, Tiswadi Goa,
India.
Received: 25 March 2014 Accepted: 19 June 2014
Published: 30 June 2014
References
1. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R: Early mortality among
adults accessing antiretroviral treatment programmes in sub-Saharan
Africa. AIDS 2008, 22(15):1897–1908.
2. Lawn SD, Harries AD, Wood R: Strategies to reduce early morbidity and
mortality in adults receiving antiretroviral therapy in resource-limited
settings. Curr Opin HIV AIDS 2010, 5(1):18–26.
3. Robertson K, Liner J, Heaton R: Neuropsychological assessment of
HIV-infected populations in international settings. Neuropsychol Rev 2009,
19(2):232–249.
4. Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London
AS, Turner BJ, Eggan F, Beckman R, Vitiello B, Morton SC, Orlando M,
Bozzette SA, Ortiz-Barron L, Shapiro M: Psychiatric disorders and drug use
among human immunodeficiency virus-infected adults in the United
States. Arch Gen Psychiatry 2001, 58(8):721–728.
5. Mayston R, Kinyanda E, Chishinga N, Prince M, Patel V: Mental disorder and
the outcome of HIV/AIDS in low-income and middle-income countries: a
systematic review. AIDS 2012, 26(Suppl 2):S117–135.
6. Azar MM, Springer SA, Meyer JP, Altice FL: A systematic review of the
impact of alcohol use disorders on HIV treatment outcomes, adherence
to antiretroviral therapy and health care utilization. Drug Alcohol Depend
2010, 112(3):178–193.
7. Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN,
Stefaniak M: Medication adherence in HIV-infected adults: effect of
patient age, cognitive status, and substance abuse. AIDS 2004,
18(Suppl 1):S19–25.
8. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland
RJ, Moore J: Mortality, CD4 cell count decline, and depressive symptoms
among HIV-seropositive women: longitudinal analysis from the HIV
Epidemiology Research Study. JAMA 2001, 285(11):1466–1474.
9. Sahay S, Phadke M, Brahme R, Paralikar V, Joshi V, Sane S, Risbud A, Mate S,
Mehendale S: Correlates of anxiety and depression among HIV
test-seekers at a Voluntary Counseling and Testing facility in Pune, India.
Qual Life Res 2007, 16(1):41–52.
10. Rochat TJ, Richter LM, Doll HA, Buthelezi NP, Tomkins A, Stein A:
Depression among pregnant rural South African women undergoing HIV
testing. JAMA 2006, 295(12):1376–1378.
11. Ramirez-Avila L, Regan S, Giddy J, Chetty S, Ross D, Katz JN, Freedberg KA,
Walensky RP: Losina E. Bassett IV: Depressive Symptoms and Their Impact
on Health-seeking Behaviors in Newly-diagnosed HIV-infected Patients in
Durban, South Africa. AIDS Behav; 2012.
12. Spitzer RL, Kroenke K, Williams JB: Validation and utility of a self-report
version of PRIME-MD: the PHQ primary care study. Primary Care
Mayston et al. BMC Psychiatry 2014, 14:188 Page 9 of 10
http://www.biomedcentral.com/1471-244X/14/188
Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999,
282(18):1737–1744.
13. Patel V, Araya R, Chowdhary N, King M, Kirkwood B, Nayak S, Simon G,
Weiss HA: Detecting common mental disorders in primary care in India:
a comparison of five screening questionnaires. Psychol Med 2008, 38
(2):221–228.
14. Lowe B, Decker O, Muller S, Brahler E, Schellberg D, Herzog W, Herzberg PY:
Validation and standardization of the Generalized Anxiety Disorder
Screener (GAD-7) in the general population. Med Care 2008,
46(3):266–274.
15. Lowe B, Grafe K, Zipfel S, Spitzer RL, Herrmann-Lingen C, Witte S, Herzog W:
Detecting panic disorder in medical and psychosomatic outpatients:
comparative validation of the Hospital Anxiety and Depression Scale, the
Patient Health Questionnaire, a screening question, and physicians'
diagnosis. J Psychosom Res 2003, 55(6):515–519.
16. Hettema JM: The nosologic relationship between generalized anxiety
disorder and major depression. Depress Anxiety 2008, 25(4):300–316.
17. Pal HR, Jena R, Yadav D: Validation of the Alcohol Use Disorders
Identification Test (AUDIT) in urban community outreach and
de-addiction center samples in north India. J Stud Alcohol 2004,
65(6):794–800.
18. D'Costa G, Nazareth I, Naik D, Vaidya R, Levy G, Patel V, King M: Harmful
alcohol use in Goa, India, and its associations with violence: a study in
primary care. Alcohol Alcohol 2007, 42(2):131–137.
19. Nayak MB, Bond JC, Cherpitel C, Patel V, Greenfield TK: Detecting alcohol-
related problems in developing countries: a comparison of 2 screening
measures in India. Alcohol Clin Exp Res 2009, 33(12):2057–2066.
20. Allen JP, Litten RZ, Fertig JB, Babor T: A review of research on the Alcohol
Use Disorders Identification Test (AUDIT). Alcohol Clin Exp Res 1997,
21(4):613–619.
21. White DA, Taylor MJ, Butters N, Mack C, Salmon DP, Peavy G, Ryan L,
Heaton RK, Atkinson JH, Chandler JL, Grant I: Memory for verbal
information in individuals with HIV-associated dementia complex. HNRC
Group. J Clin Exp Neuropsychol 1997, 19(3):357–366.
22. Ganguli M, Seaberg EC, Ratcliff GG, Belle SH, DeKosky ST: Cognitive stability
over 2 years in a rural elderly population: the MoVIES project.
Neuroepidemiology 1996, 15(1):42–50.
23. Prince M, Acosta D, Chiu H, Scazufca M, Varghese M: Dementia diagnosis
in developing countries: a cross-cultural validation study. Lancet 2003,
361(9361):909–917.
24. Kawichai S, Celentano DD, Chaifongsri R, Nelson KE, Srithanaviboonchai K,
Natpratan C, Byerer C, Khamboonruang C, Tantipiwatanaskul P: Profiles of
HIV voluntary counseling and testing of clients at a district hospital,
Chiang Mai Province, northern Thailand, from 1995 to 1999. J Acquir
Immune Defic Syndr 2002, 30(5):493–502.
25. Mmbaga EJ, Leyna GH, Mnyika KS, Hussain A, Klepp KI: Prevalence and
predictors of failure to return for HIV-1 post-test counseling in the era of
antiretroviral therapy in rural Kilimanjaro, Tanzania: challenges and
opportunities. AIDS Care 2009, 21(2):160–167.
26. Mwamburi DM, Dladla N, Qwana E, Lurie MN: Factors associated with
wanting to know HIV results in South Africa. AIDS Patient Care STDS 2005,
19(8):518–525.
27. Ramon R, La Ruche G, Sylla-Koko F, Boka-Yao A, Bonard D, Coulibaly IM,
Welffens-Ekra C, Dabis F: HIV counseling and testing: behavior and
practices of women of childbearing age in Abidjan, Cote d'Ivoire.
DYSCER-CI Group. J Acquir Immune Defic Syndr Hum Retrovirol 1998,
17(5):470–476.
28. Desai MM, Rosenheck RA: HIV testing and receipt of test results among
homeless persons with serious mental illness. Am J Psychiatry 2004,
161(12):2287–2294.
29. Ellen JM, Liang TS, Jacob CA, Erbelding E, Christmyer C: Post-HIV test
counselling of clients of a mobile STD/HIV clinic. Int J STD AIDS 2004,
15(11):728–731.
30. Chan E, McNulty A, Tribe K: Who returns for HIV screening test results? Int
J STD AIDS 2007, 18(3):171–174.
31. Cain R, Jackson R, Prentice T, Collins E, Mill J, Barlow K: The experience of
HIV diagnosis among Aboriginal people living with HIV/AIDS and
depression. Qual Health Res 2013, 23(6):815–824.
32. Jaggers JR, Dudgeon WD, Burgess S, Phillips KD, Blair SN, Hand GA:
Psychological Correlates of HIV-Related Symptom Distress. J Assoc Nurses
AIDS Care 2013, 25(4):309–317.
33. Bhatia R, Hartman C, Kallen MA, Graham J, Giordano TP: Persons newly
diagnosed with HIV infection are at high risk for depression and poor
linkage to care: results from the Steps Study. AIDS Behav 2011,
15(6):1161–1170.
34. Mayston R, Patel V, Abas M, Korgaonkar P, Paranjape R, Rodrigues S, Prince
M: Symptoms of common mental disorder and cognitive associations
with seropositivity among a cohort of people coming for testing for
HIV/AIDS in Goa, India: a cross-sectional survey. BMC Public Health 2013,
13:204.
35. Iudicello JE, Woods SP, Parsons TD, Moran LM, Carey CL, Grant I: Verbal
fluency in HIV infection: a meta-analytic review. J Int Neuropsychol Soc
2007, 13(1):183–189.
36. Gonzalez JS, Penedo FJ, Llabre MM, Duran RE, Antoni MH, Schneiderman N,
Horne R: Physical symptoms, beliefs about medications, negative mood,
and long-term HIV medication adherence. Ann Behav Med 2007,
34(1):46–55.
37. Horne R, Cooper V, Gellaitry G, Date HL, Fisher M: Patients' perceptions of
highly active antiretroviral therapy in relation to treatment uptake and
adherence: the utility of the necessity-concerns framework. J Acquir
Immune Defic Syndr 2007, 45(3):334–341.
doi:10.1186/1471-244X-14-188
Cite this article as: Mayston et al.: Psychological predictors for
attendance of post-HIV test counselling and linkage to care: the Umeed
cohort study in Goa, India. BMC Psychiatry 2014 14:188.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Mayston et al. BMC Psychiatry 2014, 14:188 Page 10 of 10
http://www.biomedcentral.com/1471-244X/14/188
